Impact Biomedical IBO
NYSE IBO
$0.46 +0.00 (+0.00%)
At close: Aug 20, 2026 · 4:00 PM EDT

Impact Biomedical (IBO) EBITDA Margin Growth (3y) (2025)

Impact Biomedical (IBO) EBITDA Margin Growth (3y) (2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn -377.00
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn -204.00
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn -537.00
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -1,934.00
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 7,261.00
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 9,003.00
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 30,461.00
8 Royalty Pharma 26.98 Bn 26.14 Bn - -2,649.00
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -11,254.00
10 Impact Biomedical 49.45 Mn 49.44 Mn 2,000.00 -

Historic Data

Download Data
DateValue
Jun 30, 2025 -1.50 Mn